IL1A and chronic kidney disease: The cytokines IL-1α and β have already been strongly associated with establishment and maintenance of the anaemic state in CKD patients, inhibiting the in vitro growth of erythroid progenitors, exerting a negative interaction on iron homeostasis, damaging erythrocyte membranes, and therefore proving to be important molecules in eliciting a blunted response to EPO.